Back to search
FDAFDA · Food and drugs·Recall number Z-0489-2015

Polyflux Revaclear Dialyzer, Model Number 110633. The Polyflux Revaclear® and Polyflux Revaclear® Max Dialyzers are single use devices intended for the treatment of acute and chronic renal failure by hemodialysis.

Published December 10, 2014 · Recall initiated: November 5, 2014

Summary

FDA records medical device Class II recall Z-0489-2015, published December 10, 2014 and initiated November 5, 2014. Recalling firm: Gambro Renal Products Inc; Status: Terminated; Reported quantity: 20 million dialyzers; Lot: Lot No. C412120501 to C412127501, C413100101 to C413129601, C414100101 to Lots C414119301 and Lot C414120001. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Gambro is initiating a field action for Polyflux Revaclear Dialyzer and Polyflux Revaclear Max Dialyzer due to potential tears in the individual packaging that may compromise the sterile barrier.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Gambro Renal Products Inc
Distributor
Worldwide Distribution: US (nationwide) including PR, and countries of: CA, BB, BM, BS, DO and LC.
Lot
Lot No. C412120501 to C412127501, C413100101 to C413129601, C414100101 to Lots C414119301 and Lot C414120001
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Polyflux Revaclear Dialyzer, Model Number 110633. The Polyflux Revaclear® and Polyflux Revaclear® Max Dialyzers are single use devices intended for the treatment of acute and chronic renal failure by hemodialysis. recalled?

Yes. FDA published recall Z-0489-2015 on December 10, 2014. Reported hazard: Gambro is initiating a field action for Polyflux Revaclear Dialyzer and Polyflux Revaclear Max Dialyzer due to potential tears in the individual packaging that may compromise the sterile barrier.

What should I do if I have this product?

Voluntary: Firm initiated · Letter